Why Is Continued Vision Loss Still a Problem in Some Patients With Diabetic Retinopathy, Despite Treatment?

Bressler, Susan B., Scanlon, Peter H ORCID: 0000-0001-8513-710X and Pearce, Elizabeth (2022) Why Is Continued Vision Loss Still a Problem in Some Patients With Diabetic Retinopathy, Despite Treatment? JAMA Ophthalmology. doi:10.1001/jamaophthalmol.2022.0135 (In Press)

Full text not available from this repository.

Abstract

Evidence suggests that most patients with diabetic retinopathy (DR) who lose vision do so because of complications of proliferative diabetic retinopathy (PDR) or diabetic macular edema (DME). Diligent screening of patients for PDR and DME followed by administration of laser treatment, anti–vascular endothelial growth factor (VEGF) therapy, or surgery can greatly reduce the risk of vision loss from these conditions.1 However, some patients with DR continue to lose vision despite treatments that ameliorate DME or PDR. Even in the best of circumstances, such as those in the DRCR Retina Network Protocol T trial,2 4% of patients receiving aflibercept, 6% of patients receiving bevacizumab, and 2% of patients receiving ranibizumab had lost at least 10 letters (approximately 2 lines) of visual acuity at 2 years. In the same trial,2 among patients with a baseline visual acuity of 20/50 to 20/320, 9% of patients receiving aflibercept, 16% of patients receiving bevacizumab, and 15% of patients receiving ranibizumab had visual acuity of 20/80 or less at 2 years, while among patients with a baseline visual acuity of 20/32 to 20/40 at baseline, 6% of patients receiving aflibercept, 6% of patients receiving bevacizumab, and 3% of patients receiving ranibizumab had a visual acuity of 20/50 or less at 2 years.2 The precise incidence and reasons underlying progressive vision loss in eyes that have been treated for either PDR or DME remain unclear and may be confounded by non–DR-related pathology such as cataracts, glaucoma, or age-related macular degeneration.

Item Type: Article
Article Type: Editorial
Uncontrolled Keywords: Ophthalmology; Ischemia; Diabetic retinopathy
Subjects: R Medicine > RA Public aspects of medicine > RA645.A-Z Individual diseases or groups of diseases, A-Z > RA645.D54 Diabetes
R Medicine > RE Ophthalmology
Divisions: Schools and Research Institutes > School of Health and Social Care
Depositing User: Susan Turner
Date Deposited: 31 Mar 2022 08:46
Last Modified: 31 Mar 2022 08:48
URI: https://eprints.glos.ac.uk/id/eprint/10894

University Staff: Request a correction | Repository Editors: Update this record

University Of Gloucestershire

Bookmark and Share

Find Us On Social Media:

Social Media Icons Facebook Twitter Google+ YouTube Pinterest Linkedin

Other University Web Sites

University of Gloucestershire, The Park, Cheltenham, Gloucestershire, GL50 2RH. Telephone +44 (0)844 8010001.